Style | Citing Format |
---|---|
MLA | Rezazadeh H, et al.. "Gamma-Aminobutyric Acid Attenuates Insulin Resistance in Type 2 Diabetic Patients and Reduces the Risk of Insulin Resistance in Their Offspring." Biomedicine and Pharmacotherapy, vol. 138, no. , 2021, pp. -. |
APA | Rezazadeh H, Sharifi MR, Sharifi M, Soltani N (2021). Gamma-Aminobutyric Acid Attenuates Insulin Resistance in Type 2 Diabetic Patients and Reduces the Risk of Insulin Resistance in Their Offspring. Biomedicine and Pharmacotherapy, 138(), -. |
Chicago | Rezazadeh H, Sharifi MR, Sharifi M, Soltani N. "Gamma-Aminobutyric Acid Attenuates Insulin Resistance in Type 2 Diabetic Patients and Reduces the Risk of Insulin Resistance in Their Offspring." Biomedicine and Pharmacotherapy 138, no. (2021): -. |
Harvard | Rezazadeh H et al. (2021) 'Gamma-Aminobutyric Acid Attenuates Insulin Resistance in Type 2 Diabetic Patients and Reduces the Risk of Insulin Resistance in Their Offspring', Biomedicine and Pharmacotherapy, 138(), pp. -. |
Vancouver | Rezazadeh H, Sharifi MR, Sharifi M, Soltani N. Gamma-Aminobutyric Acid Attenuates Insulin Resistance in Type 2 Diabetic Patients and Reduces the Risk of Insulin Resistance in Their Offspring. Biomedicine and Pharmacotherapy. 2021;138():-. |
BibTex | @article{ author = {Rezazadeh H and Sharifi MR and Sharifi M and Soltani N}, title = {Gamma-Aminobutyric Acid Attenuates Insulin Resistance in Type 2 Diabetic Patients and Reduces the Risk of Insulin Resistance in Their Offspring}, journal = {Biomedicine and Pharmacotherapy}, volume = {138}, number = {}, pages = {-}, year = {2021} } |
RIS | TY - JOUR AU - Rezazadeh H AU - Sharifi MR AU - Sharifi M AU - Soltani N TI - Gamma-Aminobutyric Acid Attenuates Insulin Resistance in Type 2 Diabetic Patients and Reduces the Risk of Insulin Resistance in Their Offspring JO - Biomedicine and Pharmacotherapy VL - 138 IS - SP - EP - PY - 2021 ER - |